Revolutionizing Drug Discovery
for Animal Health
with AI-driven Peptide Design
WHAT WE DO?
WHY WE DO IT?
OUR SOLUTION?
We use an AI-powered platform to develop novel bioactive peptides for animal health therapies
WHY PEPTIDES?
OUR DRUG DISCOVERY PROCESS
OUR PIPELINE
Candidate Name
Indication
R&D
Licensing
Candidate Name
MastPep
Indication
Bovine Mastitis
R&D
TLR6
Licensing
under-licensing
Candidate Name
PepC2
Indication
Derma healing
R&D
TLR4
Licensing
under-licensing
Candidate Name
PapA1
Indication
Injectable Anti-infective
R&D
TLR4
Licensing
under-licensing
Candidate Name
PepA2
Indication
Atopic dermatitis
R&D
TRL2
Licensing
under-licensing
Candidate Name
PepA3
Indication
Weight loss
R&D
TRL3
Licensing
under-licensing
OUR BUSINESS MODEL
TEAM PROFILE
Fabiano Cavalcante, Ph.D
Bioinformatic & A.I Advisor
EMERGE S.A
Investor & Business Advisor
AWARDS 2024 - 2025
CONTACT
Parque Tecnológico de Brasília – Lote 4, Edifício de Governança – Bloco “B”, 1º Andar – Brasília – DF – 70635-815